Molecular insights into Down syndrome-associated leukemia.

Abstract excerpt

PURPOSE OF REVIEW: Four years ago it was discovered that nearly all cases of transient myeloproliferative disorder and acute megakaryocytic leukemia in children with Down syndrome acquire mutations in the hematopoietic transcription factor gene GATA1. Studies within the past year, described within this review, have provided tremendous insights into the role of GATA1 mutations in these malignancies. RECENT...

Topics

Join the communities discussing this publication.

• Child
• Chromosomes, Human, Pair 21
• Down Syndrome
• GATA1 Transcription Factor
• Genetic Predisposition to Disease